Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Guinea-Viniegra

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Annals of the Rheumatic Diseases|February 23, 2011
Targeting inflammation by modulating the Jun/AP-1 pathwayHelia B Schonthaler, Juan Guinea-Viniegra, Erwin F Wagner
Clinical and Experimental Rheumatology|October 13, 2015
Signalling in inflammatory skin disease by AP-1 (Fos/Jun)Özge Uluçkan, Juan Guinea-Viniegra, Maria Jimenez, et al.
Nature Reviews. Rheumatology|September 30, 2010
Psoriasis: what we have learned from mouse modelsErwin F Wagner, Helia B Schonthaler, Juan Guinea-Viniegra, et al.
Journal of Cutaneous Pathology|July 29, 2021
Expression of microRNA-21 and TIMP-3 in paradoxical psoriasiform reactions during treatment with antitumor necrosis factor agentsRaquel Navarro, Yolanda Delgado-Jiménez, Juan Guinea-Viniegra, et al.
The Journal of Clinical Investigation|July 10, 2012
Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17Juan Guinea-Viniegra, Rainer Zenz, Harald Scheuch, et al.
Genes & Development|December 31, 2014
Terminal epidermal differentiation is regulated by the interaction of Fra-2/AP-1 with Ezh2 and ERK1/2Stefanie Wurm, Jisheng Zhang, Juan Guinea-Viniegra, et al.
Molecular and Cellular Biology|April 11, 2013
LOXL4 is induced by transforming growth factor β1 through Smad and JunB/Fra2 and contributes to vascular matrix remodelingOscar Busnadiego, José González-Santamaría, David Lagares, et al.
Cancer Research|September 2, 2008
Podoplanin is a novel fos target gene in skin carcinogenesisMoritz Durchdewald, Juan Guinea-Viniegra, Daniel Haag, et al.
Oncogene|June 25, 2003
Role of the p38 MAPK pathway in cisplatin-based therapyJavier Hernández Losa, Carlos Parada Cobo, Juan Guinea Viniegra, et al.
Genes & Development|November 26, 2009
TNFalpha shedding and epidermal inflammation are controlled by Jun proteinsJuan Guinea-Viniegra, Rainer Zenz, Harald Scheuch, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Annals of the Rheumatic Diseases|February 23, 2011
Targeting inflammation by modulating the Jun/AP-1 pathwayHelia B Schonthaler, Juan Guinea-Viniegra, Erwin F Wagner
Clinical and Experimental Rheumatology|October 13, 2015
Signalling in inflammatory skin disease by AP-1 (Fos/Jun)Özge Uluçkan, Juan Guinea-Viniegra, Maria Jimenez, et al.
Nature Reviews. Rheumatology|September 30, 2010
Psoriasis: what we have learned from mouse modelsErwin F Wagner, Helia B Schonthaler, Juan Guinea-Viniegra, et al.
Journal of Cutaneous Pathology|July 29, 2021
Expression of microRNA-21 and TIMP-3 in paradoxical psoriasiform reactions during treatment with antitumor necrosis factor agentsRaquel Navarro, Yolanda Delgado-Jiménez, Juan Guinea-Viniegra, et al.
The Journal of Clinical Investigation|July 10, 2012
Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17Juan Guinea-Viniegra, Rainer Zenz, Harald Scheuch, et al.
Genes & Development|December 31, 2014
Terminal epidermal differentiation is regulated by the interaction of Fra-2/AP-1 with Ezh2 and ERK1/2Stefanie Wurm, Jisheng Zhang, Juan Guinea-Viniegra, et al.
Molecular and Cellular Biology|April 11, 2013
LOXL4 is induced by transforming growth factor β1 through Smad and JunB/Fra2 and contributes to vascular matrix remodelingOscar Busnadiego, José González-Santamaría, David Lagares, et al.
Cancer Research|September 2, 2008
Podoplanin is a novel fos target gene in skin carcinogenesisMoritz Durchdewald, Juan Guinea-Viniegra, Daniel Haag, et al.
Oncogene|June 25, 2003
Role of the p38 MAPK pathway in cisplatin-based therapyJavier Hernández Losa, Carlos Parada Cobo, Juan Guinea Viniegra, et al.
Genes & Development|November 26, 2009
TNFalpha shedding and epidermal inflammation are controlled by Jun proteinsJuan Guinea-Viniegra, Rainer Zenz, Harald Scheuch, et al.
Pageof 2